Histamine 1 Receptor (H1R) |
neurons, endothelial cells, adrenal medulla, muscle cells, hepatocytes, chondrocytes, monocytes, neutrophils, eosinophils, dendritic cells (DCs), T cells, and B cells |
|
|
Histamine 2 Receptor (H2R) |
parietal cells of the gastric mucosa, muscle, epithelial, endothelial, neuronal, hepatocyte, and immune cells |
-
•
antagonizes some of the effects mediated by H1R and leads to the relaxation of smooth muscle cells, causing vasodilation.
-
•
inhibition of CXCL10, IL-12, and TNF-α stimulation of IL-10, which is likely associated with Th2 polarization
|
-
•
Observational studies [[3], [4], [5]]
-
•
Multi-site Adaptive Trials [6]
|
Histamine 3 Receptor (H3R) |
identified in the central nervous system and peripheral and presynaptic receptors |
|
|
Histamine 4 Receptor (H4R) |
preferentially expressed in the intestine, spleen, thymus, bone marrow, peripheral hematopoietic cells, and cells of the innate and adaptive immune systems. |
-
•
Activation causes chemotaxis in mast cells and eosinophils, leading to accumulation of inflammatory cells and control of cytokine secretion
-
•
increased secretion of IL-31 by Th2 cells
|
|